Based on the hospitals version of FGM data, this study took patients with early-onset T2DM as the research subjects, and compared the effect of needle-free injector and Novo pen subcutaneous insulin injection on blood sugar control and well-being index in patients with early-onset type 2 diabetes through a randomized cross-over study before and after self-control design. Here, INS is linked to type 2 diabetes mellitus.